Miriam Galbusera Selected Research

Miriam Galbusera Research Topics

Disease

9	Thrombotic Thrombocytopenic Purpura 01/2017 - 08/2002
7	Thrombosis (Thrombus) 01/2023 - 03/2005
7	Atypical Hemolytic Uremic Syndrome 01/2022 - 09/2014
4	COVID-19 01/2022 - 01/2021
4	Thrombocytopenia (Thrombopenia) 07/2011 - 08/2005
3	Hemolytic-Uremic Syndrome 01/2019 - 08/2002
2	Chronic Kidney Failure (Chronic Renal Failure) 05/2016 - 05/2005
2	Diarrhea 12/2015 - 07/2011
2	Proteinuria 08/2011 - 05/2007
2	Hemolytic Anemia 07/2011 - 03/2006
2	Hemorrhage 05/2009 - 10/2004
1	Rare Diseases (Rare Disease) 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Immunoglobulin G4-Related Disease 05/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2015
1	Hemolysis 12/2014
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 12/2014
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 09/2014
1	Diabetes Complications 10/2013
1	Membranous Glomerulonephritis (Membranous Nephropathy) 08/2011
1	Acute Kidney Injury (Acute Renal Failure) 07/2011
1	Anemia 02/2009
1	Lupus Nephritis 05/2007
1	Inflammation (Inflammations) 05/2007
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2005
1	Thrombotic Microangiopathies 08/2005
1	acquired Thrombotic thrombocytopenic purpura 08/2005
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 08/2005
1	Neurologic Manifestations (Neurological Manifestations) 05/2005

Drug/Important Bio-Agent (IBA)

14	Complement System Proteins (Complement)IBA 01/2023 - 03/2005
7	AntibodiesIBA 01/2021 - 03/2005
7	thiamine triphosphorate (TTP)IBA 11/2015 - 08/2002
5	Complement Factor H (Factor H)IBA 01/2019 - 05/2005
5	ADAMTS13 ProteinIBA 02/2009 - 08/2002
4	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2022 - 09/2014
4	eculizumab FDA Link 01/2021 - 09/2014
4	von Willebrand FactorIBA 01/2017 - 03/2005
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2005
3	Rituximab (Mabthera)FDA Link 01/2021 - 08/2005
3	Immunoglobulin G (IgG)IBA 05/2015 - 08/2005
3	AutoantibodiesIBA 08/2011 - 08/2005
2	ThrombospondinsIBA 11/2015 - 08/2005
2	DisintegrinsIBA 11/2015 - 08/2005
2	Metalloproteases (Metalloproteinases)IBA 11/2015 - 08/2005
2	P-SelectinIBA 07/2011 - 03/2005
1	SolutionsIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Adenosine Diphosphate (ADP)IBA 12/2014
1	Antigen-Antibody Complex (Immune Complex)IBA 09/2014
1	superoxide dismutase 2IBA 08/2011
1	AntigensIBA 08/2011
1	ThrombomodulinIBA 07/2011
1	FibrinIBA 07/2011
1	Complement Factor B (Factor B)IBA 07/2011
1	Shiga Toxin (Shigella Toxin)IBA 07/2011
1	estropipate (Ogen)FDA LinkGeneric 07/2011
1	AnticoagulantsIBA 05/2009
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2007
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2007
1	Peptide Hydrolases (Proteases)FDA Link 08/2005
1	ImmunosorbentsIBA 08/2005
1	EnzymesIBA 08/2005
1	Integrin alphaVbeta3IBA 03/2005
1	AntioxidantsIBA 03/2005
1	MetalsIBA 03/2005
1	P-selectin ligand proteinIBA 03/2005
1	Chelating AgentsIBA 03/2005
1	LigandsIBA 03/2005
1	1,3-dimethylthioureaIBA 03/2005
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2005
1	Complement Receptors (Complement Receptor)IBA 03/2005
1	pyrrolidine dithiocarbamic acidIBA 03/2005
1	prolinedithiocarbamate (PDTC)IBA 03/2005
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 03/2005

Therapy/Procedure

5	Therapeutics 01/2021 - 05/2007
2	Renal Dialysis (Hemodialysis) 05/2009 - 10/2004
1	Mechanical Ventilators (Ventilator) 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Continuous Positive Airway Pressure 01/2021
1	Plasmapheresis 01/2021
1	Lasers (Laser) 05/2007